The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
The global Swine Vaccines market was valued at US$ 1325.7 million in 2020 and is expected to reach US$ 1741.1 million by the end of 2029, growing at a CAGR of 4.0% during 2021-2029.
This report focuses on Swine Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Swine Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Swine Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Segment by Application
Government Tender
Market Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
1 Swine Vaccines Market Overview
1.1 Product Overview and Scope of Swine Vaccines
1.2 Swine Vaccines Segment by Type
1.2.1 Global Swine Vaccines Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines Segment by Application
1.3.1 Global Swine Vaccines Sales Comparison by Application: (2021-2029)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Vaccines Revenue 2016-2029
1.4.2 Global Swine Vaccines Sales 2016-2029
1.4.3 Swine Vaccines Market Size by Region: 2016 Versus 2021 Versus 2029
2 Swine Vaccines Market Competition by Manufacturers
2.1 Global Swine Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Swine Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Swine Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Swine Vaccines Market Competitive Situation and Trends
2.5.1 Swine Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Swine Vaccines Players Market Share by Revenue
2.5.3 Global Swine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Vaccines Retrospective Market Scenario by Region
3.1 Global Swine Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Swine Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Swine Vaccines Market Facts & Figures by Country
3.3.1 North America Swine Vaccines Sales by Country
3.3.2 North America Swine Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Swine Vaccines Market Facts & Figures by Country
3.4.1 Europe Swine Vaccines Sales by Country
3.4.2 Europe Swine Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Swine Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Swine Vaccines Sales by Region
3.5.2 Asia Pacific Swine Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Swine Vaccines Market Facts & Figures by Country
3.6.1 Latin America Swine Vaccines Sales by Country
3.6.2 Latin America Swine Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Swine Vaccines Sales by Country
3.7.2 Middle East and Africa Swine Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Swine Vaccines Historic Market Analysis by Type
4.1 Global Swine Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Swine Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Swine Vaccines Price by Type (2016-2021)
5 Global Swine Vaccines Historic Market Analysis by Application
5.1 Global Swine Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Swine Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Swine Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Swine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Corporation Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Corporation Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CAHIC Swine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Corporation Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Tecon Swine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Zoetis Swine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ceva Swine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Corporation Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Hile Bio Swine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Corporation Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Chopper Biology Swine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 WINSUN Swine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Corporation Information
6.11.2 Hipra Swine Vaccines Description and Business Overview
6.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hipra Swine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Swine Vaccines Description and Business Overview
6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 ChengDu Tecbond
6.13.1 ChengDu Tecbond Corporation Information
6.13.2 ChengDu Tecbond Swine Vaccines Description and Business Overview
6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
6.13.5 ChengDu Tecbond Recent Developments/Updates
6.14 DHN
6.14.1 DHN Corporation Information
6.14.2 DHN Swine Vaccines Description and Business Overview
6.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 DHN Swine Vaccines Product Portfolio
6.14.5 DHN Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Corporation Information
6.15.2 CAVAC Swine Vaccines Description and Business Overview
6.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 CAVAC Swine Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Virbac
6.16.1 Virbac Corporation Information
6.16.2 Virbac Swine Vaccines Description and Business Overview
6.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Virbac Swine Vaccines Product Portfolio
6.16.5 Virbac Recent Developments/Updates
6.17 HVRI
6.17.1 HVRI Corporation Information
6.17.2 HVRI Swine Vaccines Description and Business Overview
6.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.17.4 HVRI Swine Vaccines Product Portfolio
6.17.5 HVRI Recent Developments/Updates
6.18 Bioveta
6.18.1 Bioveta Corporation Information
6.18.2 Bioveta Swine Vaccines Description and Business Overview
6.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Bioveta Swine Vaccines Product Portfolio
6.18.5 Bioveta Recent Developments/Updates
7 Swine Vaccines Manufacturing Cost Analysis
7.1 Swine Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Swine Vaccines
7.4 Swine Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Swine Vaccines Distributors List
8.3 Swine Vaccines Customers
9 Swine Vaccines Market Dynamics
9.1 Swine Vaccines Industry Trends
9.2 Swine Vaccines Growth Drivers
9.3 Swine Vaccines Market Challenges
9.4 Swine Vaccines Market Restraints
10 Global Market Forecast
10.1 Swine Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Swine Vaccines by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Swine Vaccines by Type (2022-2029)
10.2 Swine Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Swine Vaccines by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Swine Vaccines by Application (2022-2029)
10.3 Swine Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Swine Vaccines by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Swine Vaccines by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Swine Vaccines Sales (M Doses) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Swine Vaccines Sales (M Doses) Comparison by Application (2021-2029)
Table 3. Global Swine Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Swine Vaccines Covered in This Study
Table 5. Global Swine Vaccines Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Swine Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Swine Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Swine Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Swine Vaccines Average Price (USD/K Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Swine Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Swine Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Swine Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Swine Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Swine Vaccines Sales by Region (2016-2021) & (M Doses)
Table 16. Global Swine Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Swine Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Swine Vaccines Sales by Country (2016-2021) & (M Doses)
Table 19. North America Swine Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Swine Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Swine Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Swine Vaccines Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Swine Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Swine Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Swine Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Swine Vaccines Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Swine Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Swine Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Swine Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Swine Vaccines Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Swine Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Swine Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Swine Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Swine Vaccines Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Swine Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Swine Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Swine Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Swine Vaccines Sales (M Doses) by Type (2016-2021)
Table 39. Global Swine Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Swine Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Swine Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Swine Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 43. Global Swine Vaccines Sales (M Doses) by Application (2016-2021)
Table 44. Global Swine Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Swine Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Swine Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Swine Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 51. Merck Swine Vaccines Product
Table 52. Merck Recent Developments/Updates
Table 53. Boehringer Ingelheim Corporation Information
Table 54. Boehringer Ingelheim Description and Business Overview
Table 55. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 56. Boehringer Ingelheim Swine Vaccines Product
Table 57. Boehringer Ingelheim Recent Developments/Updates
Table 58. Jinyu Bio-Technology Corporation Information
Table 59. Jinyu Bio-Technology Description and Business Overview
Table 60. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 61. Jinyu Bio-Technology Swine Vaccines Product
Table 62. Jinyu Bio-Technology Recent Developments/Updates
Table 63. CAHIC Corporation Information
Table 64. CAHIC Description and Business Overview
Table 65. CAHIC Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 66. CAHIC Swine Vaccines Product
Table 67. CAHIC Recent Developments/Updates
Table 68. Tecon Corporation Information
Table 69. Tecon Description and Business Overview
Table 70. Tecon Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 71. Tecon Swine Vaccines Product
Table 72. Tecon Recent Developments/Updates
Table 73. Zoetis Corporation Information
Table 74. Zoetis Description and Business Overview
Table 75. Zoetis Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 76. Zoetis Swine Vaccines Product
Table 77. Zoetis Recent Developments/Updates
Table 78. Ceva Corporation Information
Table 79. Ceva Description and Business Overview
Table 80. Ceva Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 81. Ceva Swine Vaccines Product
Table 82. Ceva Recent Developments/Updates
Table 83. Hile Bio Corporation Information
Table 84. Hile Bio Description and Business Overview
Table 85. Hile Bio Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 86. Hile Bio Swine Vaccines Product
Table 87. Hile Bio Recent Developments/Updates
Table 88. Chopper Biology Corporation Information
Table 89. Chopper Biology Description and Business Overview
Table 90. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 91. Chopper Biology Swine Vaccines Product
Table 92. Chopper Biology Recent Developments/Updates
Table 93. WINSUN Corporation Information
Table 94. WINSUN Description and Business Overview
Table 95. WINSUN Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 96. WINSUN Swine Vaccines Product
Table 97. WINSUN Recent Developments/Updates
Table 98. Hipra Corporation Information
Table 99. Hipra Description and Business Overview
Table 100. Hipra Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 101. Hipra Swine Vaccines Product
Table 102. Hipra Recent Developments/Updates
Table 103. Ringpu Biology Corporation Information
Table 104. Ringpu Biology Description and Business Overview
Table 105. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 106. Ringpu Biology Swine Vaccines Product
Table 107. Ringpu Biology Recent Developments/Updates
Table 108. ChengDu Tecbond Corporation Information
Table 109. ChengDu Tecbond Description and Business Overview
Table 110. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 111. ChengDu Tecbond Swine Vaccines Product
Table 112. ChengDu Tecbond Recent Developments/Updates
Table 113. DHN Corporation Information
Table 114. DHN Description and Business Overview
Table 115. DHN Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 116. DHN Swine Vaccines Product
Table 117. DHN Recent Developments/Updates
Table 118. CAVAC Corporation Information
Table 119. CAVAC Description and Business Overview
Table 120. CAVAC Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 121. CAVAC Swine Vaccines Product
Table 122. CAVAC Recent Developments/Updates
Table 123. Virbac Corporation Information
Table 124. Virbac Description and Business Overview
Table 125. Virbac Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 126. Virbac Swine Vaccines Product
Table 127. Virbac Recent Developments/Updates
Table 128. HVRI Corporation Information
Table 129. HVRI Description and Business Overview
Table 130. HVRI Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 131. HVRI Swine Vaccines Product
Table 132. HVRI Recent Developments/Updates
Table 133. Bioveta Corporation Information
Table 134. Bioveta Description and Business Overview
Table 135. Bioveta Swine Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 136. Bioveta Swine Vaccines Product
Table 137. Bioveta Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Swine Vaccines Distributors List
Table 141. Swine Vaccines Customers List
Table 142. Swine Vaccines Market Trends
Table 143. Swine Vaccines Growth Drivers
Table 144. Swine Vaccines Market Challenges
Table 145. Swine Vaccines Market Restraints
Table 146. Global Swine Vaccines Sales Forecast by Type (2022-2029) & (M Doses)
Table 147. Global Swine Vaccines Sales Market Share Forecast by Type (2022-2029)
Table 148. Global Swine Vaccines Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 149. Global Swine Vaccines Revenue Market Share Forecast by Type (2022-2029)
Table 150. Global Swine Vaccines Sales Forecast by Application (2022-2029) & (M Doses)
Table 151. Global Swine Vaccines Sales Market Share Forecast by Application (2022-2029)
Table 152. Global Swine Vaccines Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 153. Global Swine Vaccines Revenue Market Share Forecast by Application (2022-2029)
Table 154. Global Swine Vaccines Sales Forecast by Region (2022-2029) & (M Doses)
Table 155. Global Swine Vaccines Sales Market Share Forecast by Region (2022-2029)
Table 156. Global Swine Vaccines Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 157. Global Swine Vaccines Revenue Market Share Forecast by Region (2022-2029)
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Swine Vaccines
Figure 2. Global Swine Vaccines Market Share by Type in 2020 & 2029
Figure 3. CSF Vaccines Product Picture
Figure 4. FMD Vaccines Product Picture
Figure 5. Porcine Circovirus Vaccines Product Picture
Figure 6. PRRS Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Swine Vaccines Market Share by Application in 2020 & 2029
Figure 9. Government Tender
Figure 10. Market Sales
Figure 11. Global Swine Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 12. Global Swine Vaccines Market Size 2016-2029 (US$ Million)
Figure 13. Global Swine Vaccines Sales 2016-2029 (M Doses)
Figure 14. Global Swine Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 15. Swine Vaccines Sales Share by Manufacturers in 2020
Figure 16. Global Swine Vaccines Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Swine Vaccines Players: Market Share by Revenue in 2020
Figure 18. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Swine Vaccines Sales Market Share by Region (2016-2021)
Figure 20. Global Swine Vaccines Sales Market Share by Region in 2020
Figure 21. Global Swine Vaccines Revenue Market Share by Region (2016-2021)
Figure 22. Global Swine Vaccines Revenue Market Share by Region in 2020
Figure 23. U.S. Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Swine Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Swine Vaccines by Type (2016-2021)
Figure 48. Sales Market Share of Swine Vaccines by Application (2016-2021)
Figure 49. Sales Market Share of Swine Vaccines by Application in 2020
Figure 50. Revenue Share of Swine Vaccines by Application (2016-2021)
Figure 51. Revenue Share of Swine Vaccines by Application in 2020
Figure 52. Manufacturing Cost Structure of Swine Vaccines
Figure 53. Manufacturing Process Analysis of Swine Vaccines
Figure 54. Swine Vaccines Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
